Vousden Karen H

Vousden Karen H is listed in filings as Director at Bristol-Myers Squibb Co. This profile follows SEC Form 4 activity through Feb 3, 2026, including 1 public disclosure. Recent filings connect the profile to Bristol-Myers Squibb Co (BMY). The current snapshot covers public activity from Feb 3, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.